Conference Magazine - GoingPublic.de - Deutsches Eigenkapitalforum

Capital Seeking Companies
Profile
Founded in 2007
Number of employees 10
Equity (in EUR million) 1.6
Financing needs (in EUR million) 1.5
Positive result from 2014
Revenues in 2010 (in EUR million) 0
Revenues in 2011 (in EUR million) 0
Revenues in 2012 (e) (in EUR million) 0
Revenues in 2013 (e) (in EUR million) 0.7
Contact
Contact person Ulf Pommerening
Phone +49-(0) 3 32 03-80 47-11
E-mail ulf.pommerening@ebstech.de
Website www.ebstech.de
Address Heinrich-Hertz-Str. 4
14532 Kleinmachnow
Germany
Ulf Pommerening
Page 140 Deutsches Eigenkapitalforum 2012
EBS Technologies GmbH
Medical technology
Business field
EBS Technologies develops medical devices and innovative
therapeutic applications to treat neurological disorders,
such as a loss of vision caused by a stroke or brain injury.
The aim is to achieve neurological recovery by activating
residual brain structures through enhancing synaptic transmission
and brain synchronisation with a unique non-invasive,
pulsed electrical stimulation. The EBS therapy has
proven its efficacy in the field of vision restoration within a
large multi-centric trial. EBS will be ready to enter the market
with the CE-marked device by January 2013.
Strategic market position
With its unique and patented technology, EBS is entering a
huge market, as there is currently no therapeutic alternative
available except for month-long training procedures. EBS is
being backed by a strong group of key medical opinion
leaders in the field of brain stimulation, who in fact expect a
huge variety of future treatments using the non-invasive
EBS technology.
Management
Managing Director Ulf Pommerening, Dipl.-Betr. (FH), has
20 years’ experience in both national and international
sales and marketing and in working for large US medical
device companies in a variety of therapeutic fields and markets.
Managing Director Udo Warschewske has over 15
years of experience in developing medical devices. He has
served as Head of Development and Managing Director
within several small- and medium-sized enterprises focusing
on the development of methods and devices in the field
of image-guided surgery. He studied Mathematics and
Physics at the Free University of Berlin (Germany) and
finished his MBA in BioMed Tech at the University of Potsdam
(Germany).
Planned investment, shareholders / investors
Financial needs: EUR 1.5 million. Earlybird VC Management
GmbH & Co. KGBFB Wachstumsfonds Brandenburg
GmbH, High-Tech Gründerfonds Management GmbH